CIARDULLO, STEFANO
CIARDULLO, STEFANO
DIPARTIMENTO DI MEDICINA E CHIRURGIA (SCHOOL OF MEDICINE AND SURGERY)
Adherence to GLP1-RA and SGLT2-I affects clinical outcomes and costs in patients with type 2 diabetes
2024 Ciardullo, S; Savaré, L; Rea, F; Perseghin, G; Corrao, G
Advancements in pharmacological treatment of NAFLD/MASLD: a focus on metabolic and liver-targeted interventions
2024 Ciardullo, S; Muraca, E; Vergani, M; Invernizzi, P; Perseghin, G
Authors' response to Guo, Wei et al.
2024 Ciardullo, S; Perseghin, G
Development of a new model of insulin sensitivity in patients with type 2 diabetes and association with mortality
2024 Ciardullo, S; Dodesini, A; Lepore, G; Corsi, A; Scaranna, C; Perseghin, G; Trevisan, R
From NAFLD to MAFLD and MASLD: a tale of alcohol, stigma and metabolic dysfunction
2024 Ciardullo, S; Perseghin, G
GLP1-GIP receptor co-agonists: a promising evolution in the treatment of type 2 diabetes
2024 Ciardullo, S; Morieri, M; Daniele, G; Fiorentino, T; Mezza, T; Tricò, D; Consoli, A; Del Prato, S; Giorgino, F; Piro, S; Solini, A; Avogaro, A
Impact of MASLD and MetALD on clinical outcomes: A meta-analysis of preliminary evidence
2024 Ciardullo, S; Mantovani, A; Morieri, M; Muraca, E; Invernizzi, P; Perseghin, G
Liver fibrosis, NT-ProBNP and mortality in patients with MASLD: a population-based cohort study
2024 Ciardullo, S; Cannistraci, R; Muraca, E; Zerbini, F; Perseghin, G
NAIF: A novel artificial intelligence-based tool for accurate diagnosis of stage F3/F4 liver fibrosis in the general adult population, validated with three external datasets
2024 Hassoun, S; Bruckmann, C; Ciardullo, S; Perseghin, G; Marra, F; Curto, A; Arena, U; Broccolo, F; Di Gaudio, F
Once-weekly insulins: a promising approach to reduce the treatment burden in people with diabetes
2024 Trevisan, R; Conti, M; Ciardullo, S
Prevalence of Noninvasively Detected Clinically Significant Portal Hypertension Among U.S. Adults With and Without Diabetes
2024 Ciardullo, S; Perseghin, G
Reliability of heart rate in reflecting cardiac sympathetic overdrive in type 2 diabetes mellitus
2024 Dell'Oro, R; Quarti-Trevano, F; Ciardullo, S; Perseghin, G; Mancia, G; Grassi, G
Resmetirom for the treatment of nonalcoholic steatohepatitis: Evaluating the robustness of available evidence
2024 Ciardullo, S; Mantovani, A
Steatotic Liver Disease Phenotypes in the United States: The Impact of Alcohol Consumption Assessment
2024 Ciardullo, S; Perseghin, G
The MAFLD‐MASLD debate: Does cardiovascular risk prediction define the winner?
2024 Ciardullo, S
The Role of Natriuretic Peptides in the Management of Heart Failure with a Focus on the Patient with Diabetes
2024 Vergani, M; Cannistraci, R; Perseghin, G; Ciardullo, S
Time trends in liver-related mortality in people with and without diabetes: Results from a population based study
2024 Ciardullo, S; Morabito, G; Rea, F; Savaré, L; Perseghin, G; Corrao, G
Adherence to antidiabetic drug therapy and reduction of fatal events in elderly frail patients
2023 Rea, F; Savaré, L; Valsassina, V; Ciardullo, S; Perseghin, G; Corrao, G; Mancia, G
Authors' reply to Zou et al
2023 Ciardullo, S; Carbone, M; Invernizzi, P; Perseghin, G
Control of Blood Glucose and Cardiovascular Risk Profile
2023 Ciardullo, S; Perseghin, G